Skip to main content
. 2009 Dec 2;339:b4677. doi: 10.1136/bmj.b4677

graphic file with name bogm656173.f1_default.jpg

Fig 1 Participants with relapsing-remitting multiple sclerosis (RRMS) taking disease modifying treatments (DMT) in multiple sclerosis risk sharing scheme. *Data used for supplementary analyses. †Patients assessed as secondary progressive multiple sclerosis (SPMS) at year 1 follow-up; their EDSS scores for year 1 (but not for later years) retained in primary analysis